Carlos Bustamante

Venture Partner at F-Prime Capital Partners

Carlos Bustamante

Carlos Bustamante

Venture Partner at F-Prime Capital Partners

Overview
Career Highlights

CDB Consulting Ltd.
Arc Bio LLC

RelSci Relationships

2199

Number of Boards

3

Number of Awards

2

Relationships
RelSci Relationships are individuals Carlos Bustamante likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at F-Prime Capital Partners

Relationship likelihood: Strong

Head of Fidelity Labs at Fidelity Investments, Inc.

Relationship likelihood: Strong

Co-Founder at Invitae Corp.

Relationship likelihood: Strong

Co-Founder at Life Biosciences LLC

Relationship likelihood: Strong

Co-Founder at diaDexus, Inc.

Relationship likelihood: Strong

Vice Chairman & Chief Executive Officer at Columbia Care, Inc.

Relationship likelihood: Strong

Executive Chairman at Columbia Care, Inc.

Relationship likelihood: Strong

Associate Professor, Genetics at Stanford University - School of Medicine

Relationship likelihood: Strong

Director, Stanford Biomedical Informatics Training Program at Stanford University

Relationship likelihood: Strong

Chairman, Department of Molecular & Experimental Medicine at The Scripps Research Institute

Relationship likelihood: Strong

Paths to Carlos Bustamante
Potential Connections via
Relationship Science
You
Carlos Bustamante
Venture Partner at F-Prime Capital Partners
Education

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Venture Partner
2019 - Current

Impresa focuses on early-stage investments in start-up companies across US and International portfolio companies. There fund focuses on companies operating in the fields of biopharmaceutical, medical technology & healthcare IT and services.There funds are larger and more global. In the US and Europe, they are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, there sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai with over $2 trillion in assets under management.

Professor & Chair of Biomedical Data Science
2010 - Current

A leader in the Biomedical Revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies. Our close proximity to the resources of the university—including the Schools of Business, Law, Humanities and Sciences and Engineering—our seamless relationship with our affiliated adult and children’s hospitals and our ongoing associations with the entrepreneurial endeavors of Silicon Valley make us uniquely positioned to accelerate the pace at which new knowledge is turned into tangible health benefits.

Founder
Current
Awards & Honors
2010
MacArthur Fellowship
2007
Alfred P. Sloan Research Fellowship
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Carlos Bustamante. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Carlos Bustamante's profile does not indicate a business or promotional relationship of any kind between RelSci and Carlos Bustamante.